Freedom (FRHC) had the highest return between June 1, 2017 and July 31, 2018 by a mid-cap US stock, returning 3,259.3%.
| ASSET | DATE | % RETURN |
|---|---|---|
Freedom (FRHC) | 6/1/2017 - 7/31/2018 | 3,259.26% |
Madrigal Pharmaceuticals (MDGL) | 6/1/2017 - 7/31/2018 | 1,570.11% |
Arrowhead Pharmaceuticals (ARWR) | 6/1/2017 - 7/31/2018 | 891.16% |
Viking Therapeutics (VKTX) | 6/1/2017 - 7/31/2018 | 764.41% |
Enphase Energy (ENPH) | 6/1/2017 - 7/31/2018 | 682.89% |
Skyline (SKY) | 6/1/2017 - 7/31/2018 | 395.17% |
Sarepta Therapeutics (SRPT) | 6/1/2017 - 7/31/2018 | 289.28% |
Vericel Corp Ord (VCEL) | 6/1/2017 - 7/31/2018 | 248.33% |
Crispr Therapeutics (CRSP) | 6/1/2017 - 7/31/2018 | 246.95% |
Vicor (VICR) | 6/1/2017 - 7/31/2018 | 238.53% |
HF Sinclair (DINO) | 6/1/2017 - 7/31/2018 | 220.6% |
Warrior Met Coal (HCC) | 6/1/2017 - 7/31/2018 | 211.46% |
Etsy (ETSY) | 6/1/2017 - 7/31/2018 | 205.84% |
PTC Therapeutics (PTCT) | 6/1/2017 - 7/31/2018 | 202.86% |
Boot Barn (BOOT) | 6/1/2017 - 7/31/2018 | 197.96% |
Roku (ROKU) | 6/1/2017 - 7/31/2018 | 187.83% |
GDS (GDS) | 6/1/2017 - 7/31/2018 | 178.8% |
Novocure (NVCR) | 6/1/2017 - 7/31/2018 | 173.09% |
Quidel (QDEL) | 6/1/2017 - 7/31/2018 | 173.08% |
Xenon Pharmaceuticals (XENE) | 6/1/2017 - 7/31/2018 | 165.33% |
Crocs (CROX) | 6/1/2017 - 7/31/2018 | 163.23% |
Insperity (NSP) | 6/1/2017 - 7/31/2018 | 158.84% |
Appfolio (APPF) | 6/1/2017 - 7/31/2018 | 152.89% |
PBF Energy (PBF) | 6/1/2017 - 7/31/2018 | 149.31% |
Hamilton Lane (HLNE) | 6/1/2017 - 7/31/2018 | 148.6% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
